Helena S. Gleerup
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Plasma phosphorylated tau217 discordance with amyloid status in an ethnically diverse mixed memory clinic cohort.
Journal: Journal of the neurological sciences
Published: March 16, 2026
Corrigendum to 'Response to letter to the editor (JOTNS-D-25-02717 by Dr. Nie Lei)' [The Journal of the Neurological Sciences 2025 Volume 479 123752].
Journal: Journal of the neurological sciences
Published: December 24, 2025
Response to letter to the editor (JOTNS-D-25-02717 by Dr. Nie Lei).
Journal: Journal of the neurological sciences
Published: October 31, 2025
Saliva phosphorylated tau concentration is not associated with Alzheimer's disease, cerebrospinal fluid or blood biomarkers.
Journal: Frontiers in neuroscience
Published: October 03, 2025
Serum neurofilament light chain levels are associated with cognitive decline in a consecutive cohort of patients with Alzheimer's disease.
Journal: Journal of the neurological sciences
Published: March 10, 2025
Plasma biomarkers of amyloid, tau, astrogliosis, and axonal injury in a mixed memory clinic cohort.
Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: October 08, 2024
Synaptosomal-Associated Protein 25 kDA (SNAP-25) Levels in Cerebrospinal Fluid: Implications for Alzheimer's Disease Diagnosis and Monitoring.
Journal: Synapse (New York, N.Y.)
Published: September 18, 2024
Guidelines for the standardization of pre-analytical variables for salivary biomarker studies in Alzheimer's disease research: An updated review and consensus of the Salivary Biomarkers for Dementia Research Working Group.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: July 17, 2024
Neurofilament light chain levels in serum among a large mixed memory clinic cohort: Confounders and diagnostic usefulness.
Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: August 11, 2023
Progression of Blood-Brain Barrier Leakage in Patients with Alzheimer's Disease as Measured with the Cerebrospinal Fluid/Plasma Albumin Ratio Over Time.
Journal: Journal of Alzheimer's disease reports
Published: February 24, 2023
Cerebrospinal fluid glucose is not altered in patients with dementia.
Journal: Clinical biochemistry
Published: September 13, 2022
The Added Value of Cerebrospinal Fluid Neurofilament Light Chain to Existing Diagnostic Methods and Biomarkers in a Mixed Memory Clinic Cohort of Consecutive Patients.
Journal: Journal of Alzheimer's disease reports
Published: September 24, 2021
Last Updated: 09/26/2026